Associations between etiologic or prognostic tumor tissue markers and neighborhood contextual factors in male health professionals diagnosed with prostate cancer.

View Abstract

BACKGROUND

There is growing evidence that unfavorable neighborhood contexts may influence prostate cancer (CaP) progression. Whether these associations may be explained in part by differences in tumor-level somatic alterations remain unclear.

METHODS

Data on tumor markers (PTEN, p53, ERG, and SPINK1) were obtained from 1,157 participants with CaP in the Health Professionals Follow-up Study. Neighborhood greenness, socioeconomic status, and the income Index of Concentration at Extremes were obtained from satellite and Census data and linked to participants' address at diagnosis and at study enrollment. Exposures were scaled to an interquartile range and modeled as tertiles. Bivariate associations between tertiles of neighborhood factors and tumor markers were assessed in covariate adjusted logistic regression models to estimate odds ratios and 95% confidence intervals.

RESULTS

There was no association between any of the neighborhood contextual factors and PTEN, p53, ERG, or SPINK1 in bivariate or multivariable adjusted models. Results were generally consistent when modeling exposure using exposure at diagnosis or at study enrollment.

DISCUSSION

In this multilevel study of men with CaP, we found no evidence of associations between neighborhood context and tumor tissue markers.

IMPACT

Our results provide some of the first empirical data in support of the hypothesis that CaP risk conferred by tumor tissue markers may arise independently of underlying neighborhood context. Prospective studies in more diverse populations are needed to confirm these findings.

Investigators
Abbreviation
Cancer Epidemiol Biomarkers Prev
Publication Date
2023-05-26
Pubmed ID
37249585
Medium
Print-Electronic
Full Title
Associations between etiologic or prognostic tumor tissue markers and neighborhood contextual factors in male health professionals diagnosed with prostate cancer.
Authors
Iyer HS, Kensler KH, Vaselkiv JB, Stopsack KH, Roscoe C, Bandera EV, Qin B, Jang TL, Lotan TL, James P, Hart JE, Mucci LA, Laden F, Rebbeck TR